Liposuction for protease-inhibitor-associated lipodystrophy

Lancet

Volumn 353, Issue 9160, 1999, Pages 1244-

  Ponce de Leon, Samuel ^a   Iglesias, Martin ^a   Ceballos, Joel ^a   Ostrosky Zeichner, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LIPOSUCTION; MALE; PRIORITY JOURNAL;

EID: 0344507107     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01172-1     Document Type: Article

References (3)

1. Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS 1998; 12: 37-39.
2. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: 51-58.
3. Walli R, Herfort O, Michl GM, et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 1998; 12: 167-73.